Cabaletta Bio, Inc.
CABA
$1.59
-$0.03-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.85% | -35.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.62% | 9.92% | |||
| Operating Income | -23.62% | -9.92% | |||
| Income Before Tax | -25.55% | -10.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.55% | -10.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.55% | -10.30% | |||
| EBIT | -23.62% | -9.92% | |||
| EBITDA | -23.97% | -10.01% | |||
| EPS Basic | -2.96% | -8.97% | |||
| Normalized Basic EPS | -2.96% | -8.96% | |||
| EPS Diluted | -2.96% | -8.97% | |||
| Normalized Diluted EPS | -2.96% | -8.96% | |||
| Average Basic Shares Outstanding | 21.94% | 1.22% | |||
| Average Diluted Shares Outstanding | 21.94% | 1.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||